Compare CTNM & ITRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CTNM | ITRG |
|---|---|---|
| Founded | 2009 | 1997 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | | Precious Metals |
| Sector | | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 550.7M | 486.9M |
| IPO Year | 2024 | 2017 |
| Metric | CTNM | ITRG |
|---|---|---|
| Price | $9.57 | $1.74 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 8 |
| Target Price | ★ $21.43 | $5.13 |
| AVG Volume (30 Days) | 596.9K | ★ 1.6M |
| Earning Date | 11-03-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 0.46 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $10.03 |
| Revenue Next Year | N/A | $37.21 |
| P/E Ratio | ★ N/A | $45.07 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $6.73 | $1.77 |
| 52 Week High | $17.79 | $4.87 |
| Indicator | CTNM | ITRG |
|---|---|---|
| Relative Strength Index (RSI) | 46.25 | 29.21 |
| Support Level | $8.59 | N/A |
| Resistance Level | $13.72 | $2.96 |
| Average True Range (ATR) | 0.77 | 0.12 |
| MACD | 0.23 | -0.03 |
| Stochastic Oscillator | 42.33 | 5.75 |
Contineum Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the development of oral small-molecule therapies for neurological, inflammatory, and immunological conditions. The company focuses on developing selective compounds targeting challenging molecular pathways and has built a portfolio of small molecule drug candidates. Its pipeline includes drug candidates in clinical development, such as PIPE-791, an LPA1 receptor antagonist being studied for idiopathic pulmonary fibrosis and chronic pain, and PIPE-307, an M1 receptor inhibitor being evaluated for relapsing-remitting multiple sclerosis and other depressive disorders.
Integra Resources Corp is a precious metals exploration and development company in the Great Basin of the Western USA. Integra is currently focused on advancing its two flagship oxide heap leach projects: the past-producing DeLamar Project located in southwestern Idaho and the Nevada North Project, comprised of the Wildcat and Mountain View deposits, located in northwestern Nevada. The company also holds a portfolio of prospective early-stage exploration projects in Idaho, Nevada, and Arizona.